These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9663467)
1. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line. Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467 [TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823 [TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells. Ooi J; Tojo A; Asano S; Sato Y; Oka Y Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
5. Xanthocillins as thrombopoietin mimetic small molecules. Sakai R; Nakamura T; Nishino T; Yamamoto M; Miyamura A; Miyamoto H; Ishiwata N; Komatsu N; Kamiya H; Tsuruzoe N Bioorg Med Chem; 2005 Dec; 13(23):6388-93. PubMed ID: 16115772 [TBL] [Abstract][Full Text] [Related]
6. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase. Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147 [TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin and its receptor. Wendling F; Vainchenker W Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170 [TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811 [TBL] [Abstract][Full Text] [Related]
9. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl. Rouleau C; Cui K; Feldman L Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474 [TBL] [Abstract][Full Text] [Related]
10. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Wakao H; Chida D; Damen JE; Krystal G; Miyajima A Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines. Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683 [TBL] [Abstract][Full Text] [Related]
12. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein. Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093 [TBL] [Abstract][Full Text] [Related]
13. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl. Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143 [TBL] [Abstract][Full Text] [Related]
14. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies. Millot GA; Vainchenker W; Duménil D; Svinarchuk F Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665 [TBL] [Abstract][Full Text] [Related]
15. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Erickson-Miller CL; Pelus LM; Lord KA Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. Tilbrook PA; Bittorf T; Callus BA; Busfield SJ; Ingley E; Klinken SP Cell Growth Differ; 1996 Apr; 7(4):511-20. PubMed ID: 9052992 [TBL] [Abstract][Full Text] [Related]
17. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines. Drexler HG; Quentmeier H Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663 [TBL] [Abstract][Full Text] [Related]
18. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416 [TBL] [Abstract][Full Text] [Related]
19. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e. Quentmeier H; Zaborski M; Drexler HG Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506 [TBL] [Abstract][Full Text] [Related]
20. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]